Effects of imide analogs on enzymes required for cholesterol and fatty acid synthesis.
Twelve imide analogs were examined for their ability to lower serum cholesterol and triglyceride levels in mice. Potent activity was observed for compounds containing a phthalimide or saccharin ring structure. The ability to lower serum cholesterol appears to be related to the ability to suppress acetyl-CoA synthetase activity. The availability of acetyl-CoA in the cytoplasm is a key regulatory component for cholesterol and fatty acid synthesis. The capacity to reduce serum triglycerides was related directly to the ability of the compound to inhibit acetyl-CoA carboxylase activity, the regulatory enzyme of fatty acid synthesis.
D000106:Acetate-CoA Ligase / Q000037:antagonists & inhibitors; D000103:Acetyl-CoA Carboxylase / Q000037:antagonists & inhibitors; D000818:Animals; D002784:Cholesterol / Q000096:biosynthesis*; D064429:Fatty Acid Synthases / Q000037:antagonists & inhibitors; D005227:Fatty Acids / Q000096:biosynthesis*; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D007094:Imides / Q000494:pharmacology*; D051379:Mice
D005227:Fatty Acids; D000960:Hypolipidemic Agents; D007094:Imides; D002784:Cholesterol; D064429:Fatty Acid Synthases; D000106:Acetate-CoA Ligase; D000103:Acetyl-CoA Carboxylase